Literature DB >> 30903194

The epicardial adipose tissue and the coronary arteries: dangerous liaisons.

Rosalinda Madonna1, Marika Massaro2, Egeria Scoditti2, Irene Pescetelli1, Raffaele De Caterina3.   

Abstract

The adipose tissue (AT) is an endocrine organ that produces adipocytokines (adipokines), able to influence metabolic homeostasis. In the conventional classification, there are two large AT depots, characterized by different paracrine activities: the subcutaneous AT, which would mostly produce cytokines with protective properties against cardiovascular disease; and the visceral AT, responsible for the secretion of cytokines with proinflammatory, prothrombotic, and proatherogenic effects. A third component, the epicardial AT (EAT) is now receiving increasing attention due to its unique anatomical and functional proximity to the myocardium and the coronary arteries. In rodents, the EAT protects the heart from exposure to high levels of free fatty acids, and provides energy to the myocardium under high metabolic demands. The observation that atherosclerotic plaques are more prevalent in regions of coronary arteries surrounded by the EAT, while they tend to be less present in segments penetrating the myocardium (the septal branches and segments under myocardial bridges), has led to the hypothesis of a possible role of the EAT in promoting the development of atherosclerosis through endocrine and paracrine effects, in addition to the role of biomechanical forces affecting transendothelial lipid permeability into the intima. In this article, we review the clinical and molecular evidence linking the EAT and coronary artery disease through a systematic review of the literature. We, here, discuss current diagnostic techniques in evaluating the interaction between EAT and the onset of coronary artery disease and ischaemic heart disease. Finally, we review current knowledge on the underlying mechanisms by which the EAT may affect coronary atherosclerosis, and potential clinical implications of this interaction, making the EAT an attractive target for new therapeutics in cardiovascular disease. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Adipokines; Atherosclerosis; Coronary artery disease; Epicardial adipose tissue

Year:  2019        PMID: 30903194     DOI: 10.1093/cvr/cvz062

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  12 in total

1.  Artificial intelligence in medical imaging: A radiomic guide to precision phenotyping of cardiovascular disease.

Authors:  Evangelos K Oikonomou; Musib Siddique; Charalambos Antoniades
Journal:  Cardiovasc Res       Date:  2020-11-01       Impact factor: 10.787

2.  Chemotherapy-associated steatohepatitis was concomitant with epicardial adipose tissue volume increasing in breast cancer patients who received neoadjuvant chemotherapy.

Authors:  Xiaoxia Wang; Yuchuan Tan; Daihong Liu; Hesong Shen; Yongchun Deng; Yong Tan; Lei Wang; Yipeng Zhang; Xin Ma; Xiaohua Zeng; Jiuquan Zhang
Journal:  Eur Radiol       Date:  2022-04-08       Impact factor: 5.315

3.  Longitudinal pericardial adipose tissue changes in patients with breast cancer receiving anthracycline-based chemotherapy: a retrospective cohort study.

Authors:  Qiuzhi Chen; Chunrong Tu; Xiaoqin Li; Hesong Shen; Xing Wang; Daihong Liu; Yu Wang; Renwei Liu; Wei Den; Xiaoyue Zhang; Jiuquan Zhang
Journal:  Quant Imaging Med Surg       Date:  2022-04

Review 4.  Novel imaging biomarkers: epicardial adipose tissue evaluation.

Authors:  Caterina B Monti; Marina Codari; Carlo Nicola De Cecco; Francesco Secchi; Francesco Sardanelli; Arthur E Stillman
Journal:  Br J Radiol       Date:  2019-12-11       Impact factor: 3.039

5.  Adipocytes Directly Affect Coronary Artery Disease Pathogenesis via Induction of Adipokine and Cytokine Imbalances.

Authors:  Olga Gruzdeva; Evgenya Uchasova; Yulia Dyleva; Daria Borodkina; Olga Akbasheva; Larisa Antonova; Vera Matveeva; Ekaterina Belik; Sergei Ivanov; Anton Sotnikov; Kirill Kozyrin; Natalia Brel; Maxim Sinitsky; Victoria Karetnikova; Alexander Kokov; Evgenya Bychkova; Tamara Pecherina; Olga Barbarash
Journal:  Front Immunol       Date:  2019-09-19       Impact factor: 7.561

6.  Inhibition of Notch Signaling Promotes the Differentiation of Epicardial Progenitor Cells into Adipocytes.

Authors:  Bin Liu; Dinghui Wang; Tianhua Xiong; Yajie Liu; Xiaodong Jing; Jianlin Du; Qiang She
Journal:  Stem Cells Int       Date:  2021-04-09       Impact factor: 5.443

Review 7.  Adipogenic progenitors in different organs: Pathophysiological implications.

Authors:  Francesca Favaretto; Silvia Bettini; Luca Busetto; Gabriella Milan; Roberto Vettor
Journal:  Rev Endocr Metab Disord       Date:  2021-10-29       Impact factor: 6.514

8.  Pericardial fat, thoracic peri-aortic adipose tissue, and systemic inflammatory marker in nonalcoholic fatty liver and abdominal obesity phenotype.

Authors:  Chun-Ho Yun; Jing-Rong Jhuang; Meng-Ting Tsou
Journal:  Sci Rep       Date:  2022-02-04       Impact factor: 4.996

9.  Artificial intelligence based automatic quantification of epicardial adipose tissue suitable for large scale population studies.

Authors:  David Molnar; Olof Enqvist; Johannes Ulén; Måns Larsson; John Brandberg; Åse A Johnsson; Elias Björnson; Göran Bergström; Ola Hjelmgren
Journal:  Sci Rep       Date:  2021-12-13       Impact factor: 4.379

10.  The discrepancy of aromatase expression in epicardial adipose tissue between CHD and non-CHD patients.

Authors:  Yifan Li; Weiwei Cheng; Bin Zhao; Dongliang Ma; Xing Wei; Shunye Zhang
Journal:  Cardiovasc J Afr       Date:  2021-06-07       Impact factor: 1.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.